Generic Name and Formulations:
Hydrocortisone acetate 30mg; suppositories.
Bausch Health Companies Inc.
Indications for PROCTOCORT:
Hemorrhoids. Anorectal inflammation. Pruritus ani. Adjunct in chronic ulcerative colitis. Factitial proctitis. Cryptitis.
1 rectally in AM and PM for 2 weeks. More severe cases: 1 rectally 3 times daily or 2 rectally twice daily. Factitial proctitis: use for up to 6–8 weeks.
Tuberculosis. Diverticulitis. Discontinue if irritation develops or in uncontrolled infection. Pregnancy (Cat.C). Nursing mothers: not recommended.
Local irritation (eg, burning, itching, folliculitis, hypopigmentation), allergic contact dermatitis, secondary infection.
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|
|Renal Cell Carcinoma||Regimens||Drugs|
Cancer Therapy Advisor Articles
- Managing Immune-Related Adverse Events
- PD-1/PD-L1 Inhibitors May Increase the Risk of Hyperprogressive Disease in NSCLC
- Genetic Counseling Recommended for Advanced Prostate Cancer
- BRCA1/Shieldin Double Mutations May Signal Resistance to PARP Inhibitors
- "Impressive" CNS Responses With Osimertinib Compared With Standard EGFR-TKIs in Patients With CNS Metastases at Baseline
- Higher Doses of Image-Guided Neoadjuvant Radiation Therapy Found to Be Safe in Locally Advanced NSCLC: Study
- Supply Shortages of Bacillus Calmette-Guérin Found to Spur Drug Rationing in Non-Muscle-Invasive Bladder Cancer
- Study Analyzing Postmarketing Data on Breast Implant Safety Sparks FDA Response
- Epacadostat and Pembrolizumab Combo Active in Relapsed NSCLC
- PD-1 Inhibitor Cemiplimab Shows Antitumor Activity in Relapsed NSCLC